Further analysis of the cognitive effects of tetrahydroaminoacridine (THA) in Alzheimer's disease: assessment of attentional and mnemonic function using CANTAB

Sahakian, Barbara J., Owen, Adrian M., Morant, Nicola J., Eagger, Sarah A., Boddington, Stephen, Crayton, Lissa, Crockford, Helena A., Crooks, Maureen +2 more·1993·Psychopharmacology
DOI 10.1007/bf02244644

Cited by (227)

Items 101–200 of 227

  1. Sleep duration over 28 years, cognition, gray matter volume, and white matter microstructure: a prospective cohort study
    Jennifer Zitser, Melis Anatürk, Enikő Zsoldos, Abda Mahmood, Nicola Filippini, Sana Suri, Yue Leng, Kristine S. Yaffe, Archana Singh‐Manoux, Mika Kivimaki B et al. · 2020 · SLEEP
  2. Tetrahydroaminoacridine (THA) in Alzheimer's disease: An assessment of attentional and mnemonic function using CANTAB
    Barbara Jacquelyn Sahakian, Jennifer T. Coull · 2009 · Acta Neurologica Scandinavica
  3. Predicting the outcome of cholinesterase inhibitor treatment in Alzheimer's disease
    Peter Connelly · 2005 · Journal of Neurology Neurosurgery & Psychiatry
  4. Blockade of nicotinic responses by physostigmine, tacrine and other cholinesterase inhibitors in rat striatum
    Paul B. S. Clarke, Melanie Reuben, Hiba El-Bizri · 1994 · British Journal of Pharmacology
  5. Neuronal mechanisms mediating drug-induced cognition enhancement: cognitive activity as a necessary intervening variable
    Martin F. Sarter, John P. Bruno, Bennet S. Givens, Holly M Moore, Jill A. McGaughy, Kathy McMahon · 1996 · Cognitive Brain Research
  6. Acetylcholine Facilitates Recovery of Episodic Memory after Brain Damage
    Paula L. Croxson, Philip G. F. Browning, David Gaffan, Mark G. Baxter · 2012 · Journal of Neuroscience
  7. Computerized neuropsychological testing in epilepsy: Overview of available tools
    Juri‐Alexander Witt, W.C.J. Alpherts, Christoph Helmstaedter · 2013 · Seizure
  8. Novel tacrine derivatives that block neuronal calcium channels
    Cristóbal de los Rı́os · 2002 · Bioorganic & Medicinal Chemistry
  9. Do Cholinesterase Inhibitors Act Primarily on Attention Deficit? A Naturalistic Study in Alzheimer's Disease Patients
    Laura Bracco, Valentina Bessi, Sonia Padiglioni, Sandro Marini, Giancarlo Pepeu · 2014 · Journal of Alzheimer s Disease
  10. Translational Rodent Paradigms to Investigate Neuromechanisms Underlying Behaviors Relevant to Amotivation and Altered Reward Processing in Schizophrenia
    Jared W. Young, Athina Markou · 2015 · Schizophrenia Bulletin
  11. New multipotent tetracyclic tacrines with neuroprotective activity
    Jose Luis Marco, Rafael M. Leon, Cristóbal de los Rı́os, Antonio G. Garcı́a, Manuela G. López, Mércedes Villarroya · 2006 · Bioorganic & Medicinal Chemistry
  12. Regional Cerebral Blood Flow Patterns and Response to Donepezil Treatment in Patients with Alzheimer’s Disease
    Haruo Hanyu, Takeshi Shimizu, Yuriko Tanaka, Masaru Takasaki, Kiyoshi Koizumi, Kimihiko Abe · 2003 · Dementia and Geriatric Cognitive Disorders
  13. SPECT Follow-Up Study of Cerebral Blood Flow Changes During Donepezil Therapy in Patients with Alzheimer's Disease
    Soichiro Shimizu, Haruo Hanyu, Toshihiko Iwamoto, Kiyoshi Koizumi, Kimihiko Abe · 2006 · Journal of Neuroimaging
  14. Nonverbal visual attention, but not recognition memory or learning, processes are impaired in motor neurone disease
    Ganesh Chari, Pamela J. Shaw, Arjun Sahgal · 1996 · Neuropsychologia
  15. Touchscreen cognitive testing: Cross-species translation and co-clinical trials in neurodegenerative and neuropsychiatric disease
    Daniel D. Palmer, Julie R. Dumont, Tyler D. Dexter, Marco A. M. Prado, Elizabeth C. Finger, Timothy J. Bussey, Lisa M. Saksida · 2021 · Neurobiology of Learning and Memory
  16. Specific impairments in visuospatial working and short-term memory following low-dose scopolamine challenge in healthy older adults
    Elizabeth H. X. Thomas, Peter Jeffrey Snyder, Robert H. Pietrzak, Colleen E. Jackson, Martin M. Bednar, Paul T. Maruff · 2008 · Neuropsychologia
  17. Reduced attention in mice overproducing corticotropin-releasing hormone
    Marcel M. van Gaalen, Mary P. Stenzel‐Poore, F Holsboer, Thomas Steckler · 2003 · Behavioural Brain Research
  18. Magnetic resonance imaging in late-life depression: vascular and glucocorticoid cascade hypotheses
    Claire E. Sexton, Marisa Le Masurier, Charlotte L. Allan, Mark Jenkinson, Lisa M. McDermott, Ukwuori G. Kalu, Lucie L. Herrmann, Kevin Martin Bradley, Clare E. Mackay, Klaus P. Ebmeier · 2012 · The British Journal of Psychiatry
  19. Physostigmine Reversal of Scopolamine-Induced Hypofrontality
    I. Prohovnik, Steven Edward Arnold, G. Smith, Louis Lucas · 1997 · Journal of Cerebral Blood Flow & Metabolism
  20. Saccade and Cognitive Function in Chronic Kava Users
    Sheree J. Cairney, ALAN R. CLOUGH, Paul T. Maruff, Alex Collie, Bart J. Currie, Jon Currie · 2003 · Neuropsychopharmacology
  21. Tacrine efficacy in Lewy body dementia
    Florence Lebert, Florence Pasquier, Lydie Soûliez, H Petit · 1998 · International Journal of Geriatric Psychiatry
  22. Reversal of visual attention dysfunction after AMPA lesions of the nucleus basalis magnocellularis (NBM) by the cholinesterase inhibitor donepezil and by a 5-HT1A receptor antagonist WAY 100635
    Balducci, C., Nurra, M., Pietropoli, A., Samanin, R., Carli, M. · 2003 · Psychopharmacology
  23. Rodent Test of Attention and Impulsivity: The 5‐Choice Serial Reaction Time Task
    Guy A. Higgins, Leo B. Silenieks · 2017 · Current Protocols in Pharmacology
  24. Modulation of fusiform cortex activity by cholinesterase inhibition predicts effects on subsequent memory
    Bentley, P., Driver, J., Dolan, R.J. · 2009 · Brain
  25. Pharmaceutical treatment for cognitive deficits in Alzheimer’s disease and other neurodegenerative conditions: exploring new territory using traditional tools and established maps
    Raymond T. Bartus, Reginald L. Dean · 2008 · Psychopharmacology
  26. Depolarization preconditioning produces cytoprotection against veratridine-induced chromaffin cell death
    Camilo Orozco, Antonio M. G. de Diego, Esperanza Arias, Jesús Miguel Hernández-Guijo, Antonio M. G. de Diego, Mércedes Villarroya, Manuela G. López · 2006 · European Journal of Pharmacology
  27. Cognitive Translation Using the Rodent Touchscreen Testing Approach
    Martha Hvoslef‐Eide, Simon R. O. Nilsson, Lisa M. Saksida, Timothy J. Bussey · 2015 · Current topics in behavioral neurosciences
  28. Concurrent Monitoring of EEG and Performance in the Common Marmoset: A Methodological Approach
    Peter C Pearce, Harriet S. Crofts, Neil Gerald Muggleton, Elizabeth A. Scott · 1998 · Physiology & Behavior
  29. Donepezil reverses a mnemonic deficit produced by scopolamine but not by perforant path lesion or transient cerebral ischaemia
    Guy A. Higgins, M Enderlin, R. Fimbel, Marie Haman, Andrew J. Grottick, Marc Aureli Soriano, John Grayson Richards, John A. Kemp, Rammy Gill · 2002 · European Journal of Neuroscience
  30. The potent and selective dopamine D1 receptor agonist A-77636 increases cortical and hippocampal acetylcholine release in the rat
    Elio Acquas, Jamie C. Day, Hans C. Fibiger · 1994 · European Journal of Pharmacology
  31. Signal detection behavior in humans and rats: a comparison with matched tasks
    Philip J. Bushnell, Vernon A. Benignus, Martin Case · 2003 · Behavioural Processes
  32. Synthesizing Schizophrenia: A Bottom-Up, Symptomatic Approach
    Trevor William Robbins · 2005 · Schizophrenia Bulletin
  33. Clonidine impairs sustained attention and memory in Alzheimer's disease
    Minna Riekkinen, Mikko P. Laakso, Pekka Jäkälä, Paavo Riekkinen · 1999 · Neuroscience
  34. Analysis of galanin and the galanin antagonist M40 on delayed non-matching-to-position performance in rats lesioned with the cholinergic immunotoxin ¹⁹²IgG-Saporin.
    Michael P. McDonald, Gary L. Wenk, Jacqueline N. Crawley · 1997 · Behavioral Neuroscience
  35. Attention and the Cholinergic System: Relevance to Schizophrenia
    Cindy Lustig, Martin F. Sarter · 2015 · Current topics in behavioral neurosciences
  36. Rodent Model of Attention: The 5‐Choice Serial Reaction Time Task
    Guy A. Higgins, Nathalie Breysse · 2008 · Current Protocols in Pharmacology
  37. Trans-Synaptic Stimulation of Cortical Acetylcholine Release after Partial 192 IgG-Saporin-Induced Loss of Cortical Cholinergic Afferents
    Jim R. Fadel, Holly M Moore, Martin F. Sarter, John P. Bruno · 1996 · Journal of Neuroscience
  38. Regulation of cortical acetylcholine release: Insights from in vivo microdialysis studies
    Jim R. Fadel · 2010 · Behavioural Brain Research
  39. Differential Cognitive Deterioration in Dementia: A Two Year Longitudinal Study
    Samuel Robin Chamberlain, Andrew D. Blackwell, Pradeep J. Nathan, Geoff Hammond, Trevor William Robbins, John R. Hodges, Albert Michael, James M. Semple, Edward Thomas Bullmore, Barbara Jacquelyn Sahakian · 2011 · Journal of Alzheimer s Disease
  40. New classes of carbazoles as potential multi-functional anti-Alzheimer’s agents
    Niloufar Choubdar, Mostafa Golshani, Leili Jalili‐Baleh, Hamid Nadri, Tuba Tüylü Küçükkılınç, Beyza Ayazgök, Alireza Moradi, Farshad Homayouni Moghadam, Zahra Abdolahi, Alieh Ameri et al. · 2019 · Bioorganic Chemistry
  41. Effects of piracetam on indices of cognitive function in a delayed alternation task in young and aged rats
    Sylvain Roux, Isabelle Hubert, Antoine Lenègre, Daniel Milinkevitch, Roger D. Porsolt · 1994 · Pharmacology Biochemistry and Behavior
  42. What do experts think we should do to achieve brain health?
    Barbara Jacquelyn Sahakian · 2014 · Neuroscience & Biobehavioral Reviews
  43. Neuropsychology -- dementia and affective disorders
    Trevor William Robbins, Rebecca Elliott, Barbara Jacquelyn Sahakian · 1996 · British Medical Bulletin
  44. THA Improves Word Priming and Clonidine Enhances Fluency and Working Memory in Alzheimer's Disease
    Paavo J. Riekkinen · 1999 · Neuropsychopharmacology
  45. Influence of prefeeding and scopolamine upon performance in a delayed matching-to-position task
    Deborah L. Kirkby, Declan N.C. Jones, Guy A. Higgins · 1995 · Behavioural Brain Research
  46. The effects of an aerobic training intervention on cognition, grey matter volumes and white matter microstructure
    Claire E. Sexton, J F Betts, Andrea Dennis, Aiden Doherty, Paul Leeson, Cameron J. Holloway, Erica Dall’Armellina, Anderson M. Winkler, Naiara Demnitz, Thomas M. Wassenaar et al. · 2020 · Physiology & Behavior
  47. Tetrahydroaminoacridine and d-cycloserine stimulate acquisition of water maze spatial navigation in aged rats
    Juhana Aura, Minna Riekkinen, Paavo J. Riekkinen · 1998 · European Journal of Pharmacology
  48. Animal models of memory impairment
    The American Association for Research into Nervous and Mental Diseases, Michela Gallagher · 1997 · Philosophical Transactions of the Royal Society B Biological Sciences
  49. PSYCHOMETRIC properties of the Chinese version of the THINC-it tool for cognitive symptoms in patients with major depressive disorder
    Yanyan Hou, Shuqiao Yao, Shaohua Hu, Qi Zhou, Han Han, Xin Yu, Roger S. McIntyre, Chuan Shi · 2020 · Journal of Affective Disorders
  50. Animal Paradigms to Assess Cognition with Translation to Humans
    Wallace, Tanya L., Ballard, Theresa M., Glavis-Bloom, Courtney · 2015 · Handbook of Experimental Pharmacology
  51. Cognitive Predictors of Donepezil Therapy Response in Alzheimer Disease
    Daniel Saumier, Susan J. E. Murtha, Howard Bergman, Natalie D. Phillips, Victor Whitehead, Howard Mark Chertkow · 2007 · Dementia and Geriatric Cognitive Disorders
  52. Cognitive function in healthy older European adults: the ZENITH study
    Ellen E. A. Simpson, Elizabeth Ann Maylor, Gordon Rae, Nathalie Meunier, Maud Andriollo-Sanchez, Giovina Catasta, Christopher McConville, M. Ferry, Angela Polito, Barbara J Stewart-Knox et al. · 2005 · European Journal of Clinical Nutrition
  53. Prediction of response to donepezil in Alzheimer's disease: combined MRI analysis of the substantia innominata and SPECT measurement of cerebral perfusion
    Hidekazu Kanetaka, Haruo Hanyu, Kentaro Hirao, Soichiro Shimizu, T. Sato, Tomotaka Akai, Toshihiko Iwamoto, Kiyoshi Koizumi · 2008 · Nuclear Medicine Communications
  54. The evaluation of cognitive function in the dementias: methodological and regulatory considerations
    Keith Andrew Wesnes, John Harrison · 2003 · Dialogues in Clinical Neuroscience
  55. The “Kynurenate Test,” a Biochemical Assay for Putative Cognition Enhancers
    Anna Pittaluga, Daniella Vaccari, Maurizio Raiteri · 1997 · Journal of Pharmacology and Experimental Therapeutics
  56. Assessing Attention in Rodents
    Barbara J. Strupp, Philip J. Bushnell · 2008 · Frontiers in neuroscience
  57. Effects of cholinesterase inhibition on attention and working memory in Lewy body dementias
    S. Fallon, Olivia Plant, Y. Tabi, S. Manohar, M. Husain · 2023 · Brain Communications
  58. Boosting Working Memory
    Trevor William Robbins, Mitul Ashok Mehta, Barbara Jacquelyn Sahakian · 2000 · Science
  59. Tetrahydroaminoacridine improves the recency effect in Alzheimer's disease
    Minna Riekkinen, Hilkka S. Soininen, Paavo J. Riekkinen, Jyrki T. Kuikka, Mikko P. Laakso, E.-L. Helkala, Juhani V Partanen, Paavo J. Riekkinen · 1998 · Neuroscience
  60. Self-Disorders, Neurocognition and Rationality in Schizophrenia: A Preliminary Study
    Julie Nordgaard, Rasmus Revsbech, Mads Gram Henriksen · 2015 · Psychopathology
  61. Scopolamine model of delirium in rats and reversal of the performance impairment by aniracetam
    Kazuo Nakamura, Mitsue Kurasawa, Yushiro Tanaka · 1998 · Drug Development Research
  62. Cholinergic drug effects on a delayed conditional discrimination task in the rat.
    Arnoud H. J. Herremans, Theo H. Hijzen, Berend Olivier, Jef L. Slangen · 1995 · Behavioral Neuroscience
  63. Longitudinal evaluation of Tau‐P301L transgenic mice reveals no cognitive impairments at 17 months of age
    Brianne A. Kent, Christopher J. Heath, Chi Hun Kim, Rosemary Ahrens, Paul E. Fraser, Peter St George‐Hyslop, Timothy J. Bussey, Lisa M. Saksida · 2017 · Brain and Behavior
  64. Progress in Clinical Neurosciences: Canadian Guidelines for the Development of Antidementia Therapies: A Conceptual Summary
    Howard Feldman, Serge G. Gauthier, Howard Mark Chertkow, David K. Conn, Morris Freedman, Chris MacKnight, for the 2nd Canadian Conference on Antidementia Guidelines · 2006 · Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques
  65. Cognition and interpersonal coordination of patients with schizophrenia who have sports habits
    Keisuke Fujii, Yujiro Yoshihara, Yukiko Matsumoto, Keima Tose, Hideaki Takeuchi, Masanori Isobe, Hiroto Mizuta, Daisuke Maniwa, Takehiko Okamura, Toshiya Murai et al. · 2020 · PLoS ONE
  66. Antagonism of scopolamine-induced memory impairments in rats by the muscarinic agonist RU 35 926 (CI-979)
    Mohammed M'Harzi · 1995 · Pharmacology Biochemistry and Behavior
  67. Behavioural and molecular endophenotypes in psychotic disorders reveal heritable abnormalities in glutamatergic neurotransmission
    Linda Scoriels, Reza M. Salek, Emmeline Goodby, D Grainger, A. M. Dean, J A West, Julian Leether Griffin, John Suckling A, P.J. Nathan, Belinda Lennox et al. · 2015 · Translational Psychiatry
  68. Computerized cognition assessment during acetylcholinesterase inhibitor treatment in Alzheimer’s disease
    Keith Andrew Wesnes, Chris J. Edgar, Nancy C. Andreasen, Peter Annas, Hans Basun, Lars Lannfelt, Henrik Zetterberg, Kaj Blennow, Lennart Minthon · 2009 · Acta Neurologica Scandinavica
  69. Treatment effects in multiple cognitive domains in Alzheimer’s disease: a two-year cohort study
    Pearl Behl, Jodi D. Edwards, Alexander Kiss, Krista L. Lanctôt, David L. Streiner, Sandra E. Black, Donald T. Stuss · 2014 · Alzheimer s Research & Therapy
  70. Translational cognitive systems: focus on attention
    Benjamin Z. Roberts, Jared W. Young · 2022 · Emerging Topics in Life Sciences
  71. A comprehensive preclinical assessment of late-term imaging markers of radiation-induced brain injury
    Tien T. Tang, Janice A. Zawaski, Shelli R. Kesler, Christine A. Beamish, Wilburn E. Reddick, John O. Glass, Darrell H. Carney, Omaima M. Sabek, David R. Grosshans, M. Waleed Gaber · 2019 · Neuro-Oncology Advances
  72. Chapter 1 Toward a Cognitive Neuroscience of Normal Aging
    Peter R. Rapp, Michela Gallagher · 1997 · Advances in cell aging and gerontology
  73. Exploring rationality in schizophrenia
    Rasmus Revsbech, Erik Lykke Mortensen, Gareth S. Owen, Julie Nordgaard, Lennart Jansson, Ditte Sæbye, Trine Flensborg‐Madsen, Josef Parnas · 2015 · BJPsych Open
  74. Memory
    Hans Joachim Markowitsch · 2003 · Neurological Disorders
  75. Memory disorders: Novel treatments, clinical perspective
    Giancarlo Pepeu · 1994 · Life Sciences
  76. Activation of Cerebral Function by CS-932, a Functionally Selective M1 Partial Agonist: Neurochemical Characterization and Pharmacological Studies
    Nobuyoshi Iwata, Masao Kozuka, Takao Hara, Tsugio Kaneko, Toshiyuki Tonohiro, Masahiko Sugimoto, Yoichi Niitsu, Yusuke Kondo, Tsuneyuki Yamamoto, Junichi Sakai et al. · 2000 · The Japanese Journal of Pharmacology
  77. Cholinergic Nicotinic Systems in Alzheimer??s Disease
    Robyn Vesey, Jennifer M. Birrell, Clare Bolton, Ruth S. Chipperfield, Andrew D. Blackwell, Tom Dening, Barbara Jacquelyn Sahakian · 2002 · CNS Drugs
  78. Minimal effects of dextroamphetamine on scopolamine-induced cognitive impairments in humans
    Rick A. Martínez, Susan E. Molchan, BRIAN A. LAWLOR, Karen Thompson, Heidi Martinson, Georgia Latham, Herbert Weingartner, Trey Sunderland · 1997 · Biological Psychiatry
  79. Cognitive performance improvement in Canadian Armed Forces personnel during deployment
    Asad Makhani, Farzad Akbaryan, Ibolja Černak · 2015 · Journal of Military Veteran and Family Health
  80. Evaluation of symptomatic drug effects in Alzheimer's disease: strategies for prediction of efficacy in humans
    Julie Deguil, L. Ravasi, Alexandra Auffret, Claudio Babiloni, David Bartrés-faz A, Véronique Bragulat, Catherine Cassé‐Perrot, Valeria Colavito, M.T. Herrero Ezquerro, Yves Lamberty et al. · 2013 · Drug Discovery Today Technologies
  81. Ameliorating Effects of RU 47213, A Novel Oral and Long-lasting Cholinomimetic Agent, on Working Memory Impairments in Rats
    Mohammed M'Harzi, F. Willig, C Gieules, A.-M Palou, Claude Oberlander, Fernando Barzaghi · 1997 · Pharmacology Biochemistry and Behavior
  82. Chronic sparing of delayed alternation performance and choline acetyltransferase activity by CEP-1347/KT-7515 in rats with lesions of nucleus basalis magnocellularis
    Amy DiCamillo, Nicola T. Neff, Susan Carswell, Forrest Haun · 1998 · Neuroscience
  83. Acetylcholinesterase inhibitors reduce spreading activation in dementia
    Paul S. Foster, Kaylei K. Branch, John C. Witt, Tania Giovannetti, David J. Libon, Kenneth M. Heilman, Valeria Drago · 2012 · Neuropsychologia
  84. Pharmacokinetics, pharmacodynamics and safety of CEP-26401, a high-affinity histamine-3 receptor antagonist, following single and multiple dosing in healthy subjects
    Ofer Spiegelstein, Jasper Stevens, Joop van Gerven, Pradeep J. Nathan, James Maynard, David W. Mayleben, Edward T. Hellriegel, Ronghua Yang · 2016 · Journal of Psychopharmacology
  85. Immediate and Long-term Neurocognitive Outcome in Patients with Obstructive Sleep Apnea Syndrome After Continuous Positive Airway Pressure Treatment
    Shih‐Wei Lin, Yu-Ting Chou, Kuo‐Chin Kao, Li‐Pang Chuang, Chien‐Ming Yang, Han‐Chung Hu, Chung-Chi Huang, Cheng‐Ta Yang, Ning‐Hung Chen · 2014 · Indian Journal of Otolaryngology and Head & Neck Surgery
  86. Cholinesterase-inhibitor Therapy for Dementia: Novel Clinical Substrates and Mechanisms for Treatment Response
    Daniel Kaufer · 2002 · CNS Spectrums
  87. Preclinical Evaluation of Attention and Impulsivity Relevant to Determining ADHD Mechanisms and Treatments
    Johnny A. Kenton, Jared W. Young · 2022 · Current topics in behavioral neurosciences
  88. PHYSICAL ACTIVITY AND SEDENTARY BEHAVIOUR IN ASSOCIATION WITH ACADEMIC PERFORMANCE AND COGNITIVE FUNCTIONS IN SCHOOL-AGED CHILDREN
    Heidi J. Syväoja · 2014 · Jyväskylä University Digital Archive (University of Jyväskylä)
  89. Analysis of Electrodermal Activity Signal Collected During Visual Attention Oriented Tasks
    Abdul Momin, Sudip Sanyal · 2019 · IEEE Access
  90. Spontaneous response tendencies in noncontingent trials of a matching-to-position task in rats: Consequences for learning the matching and nonmatching task contingencies
    Arjan Blokland, Stephen B. Dunnett · 1995 · Psychobiology
  91. Synthesis of novel chromeno[4′,3′- b ]pyrano[6,5- b ]quinoline derivatives
    Radineh Motamedi · 2011 · Heterocyclic Communications
  92. Tetrahydroaminoacridine and d-cycloserine fail to alleviate the water maze spatial navigation defect induced by hippocampal inactivation
    Paavo J. Riekkinen, Sami Ikonen, Juhana Aura, Minna Riekkinen · 1999 · European Journal of Pharmacology
  93. Conditioning learning in an attentional task relates to age and ventricular expansion in a nonhuman primate (Microcebus murinus)
    Jennifer Wittkowski, Rebecca Grace Fritz, Martin Meier, Daniel Schmidtke · 2020 · Behavioural Brain Research
  94. Selective Cholinergic Neurotoxins
    Thomas J. Walsh, Pamela E. Potter · 1998 · Humana Press eBooks
  95. The Granular Retrosplenial Cortex Is Necessary in Male Rats for Object-Location Associative Learning and Memory, But Not Spatial Working Memory or Visual Discrimination and Reversal, in the Touchscreen Operant Chamber
    Paul A. S. Sheppard, Charlotte A. Oomen, Timothy J. Bussey, Lisa M. Saksida · 2024 · eNeuro
  96. Enhancement of the left frontoparietal network through real‐time functional magnetic resonance imaging functional connectivity–informed neurofeedback and its impact on working memory in schizophrenia: A pilot study
    Yuko Kobayashi, Tomohisa Asai, Yujiro Yoshihara, Masahiro Yamashita, Hironobu Nakamura, Masaaki Shimizu, Takahiko Kawashima, Jun Miyata, Mitsuo Kawato, Toshiya Murai et al. · 2025 · Psychiatry and Clinical Neurosciences
  97. Non-mnestic cognitive function in the scopolamine model of Alzheimer's Disease
    Marc Claude Obonsawin, A. H. J. Robertson, John R. Crawford, Chris Perera, Shona A. Walker, Louise Blackmore, DENIS M. PARKER, JOHN A. O. BESSON · 1998 · Human Psychopharmacology Clinical and Experimental
  98. Inhibitory effects of tacrine and physostigmine on catecholamine secretion and membrane currents in guinea‐pig adrenal chromaffin cells
    Takeshi Sugawara, Naoki Kitamura, T Ohta, Saya Ito, Yoshikazu Nakazato · 1998 · Fundamental and Clinical Pharmacology
  99. Exploring social cognition in schizophrenia
    Rasmus Revsbech, Erik Lykke Mortensen, Julie Nordgaard, Lennart Jansson, Ditte Sæbye, Trine Flensborg‐Madsen, John Cutting, Josef Parnas · 2016 · European Archives of Psychiatry and Clinical Neuroscience
  100. Tacrine inhibits nicotinic secretory and current responses in adrenal chromaffin cells
    Takeshi Sugawara, Toshio Ohta, Tadashi Asano, Shigeo Ito, Yoshikazu Nakazato · 1997 · European Journal of Pharmacology